"Your health and safety are always our top priority. To help you protect yourself and your loved ones, we’ve gathered the most important information and guidance on the coronavirus and COVID-19. Go to our website. You have many ways to get care without leaving the comfort of your home - including an e-visit, phone, video appointments and email. This allows you to still get great care while helping to address the community spread of COVID-19. To book an in-person appointment, or if you’re concerned about your specific health condition, visit our website for your local information on appointments and 24/7 advice."

During the past decade, Kaiser Permanente-Rancho Cordova Cancer Center conducted 61 clinical trials. In the 10-year time frame, 61 clinical trials started and 21 clinical trials were completed, i.e. on average, 34.4% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 15 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kaiser Permanente-Rancho Cordova Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 30 trials, followed by "NRG Oncology" with 16 trials sponsored, "SWOG Cancer Research Network" with 8 trials sponsored, "Radiation Therapy Oncology Group" with 7 trials sponsored and "Alliance for Clinical Trials in Oncology" with 7 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kaiser Permanente-Rancho Cordova Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 45 trials as a collaborator, "NRG Oncology" with 20 trials as a collaborator, "Canadian Cancer Trials Group" with 4 trials as a collaborator, "Radiation Therapy Oncology Group" with 4 trials as a collaborator and "Alliance for Clinical Trials in Oncology" with 2 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Kaiser Permanente-Rancho Cordova Cancer Center" are "Stage II Breast Cancer" (5 trials), "Lung Non-Squamous Non-Small Cell Carcinoma" (4 trials), "Prostate Cancer" (4 trials), "Stage IIIA Breast Cancer" (4 trials) and "Gliosarcoma" (3 trials). Many other conditions were trialed in "Kaiser Permanente-Rancho Cordova Cancer Center" in a lesser frequency.

Most popular intervention types in "Kaiser Permanente-Rancho Cordova Cancer Center" are "Drug" (52 trials), "Other" (42 trials), "Radiation" (32 trials), "Biological" (27 trials) and "Procedure" (21 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (20 trials), "Quality-of-Life Assessment" (19 trials), "Questionnaire Administration" (13 trials), "Cisplatin" (12 trials) and "Carboplatin" (11 trials). Other intervention names were less common.

The vast majority of trials in "Kaiser Permanente-Rancho Cordova Cancer Center" are 57 trials for "All" genders, 11 trials for "Female" genders and 9 trials for "Male" genders.

Currently, there are NaN active trials in "Kaiser Permanente-Rancho Cordova Cancer Center". undefined are not yet recruiting, 22 are recruiting, 42 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Kaiser Permanente-Rancho Cordova Cancer Center, 3 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Kaiser Permanente-Rancho Cordova Cancer Center, 1 "Phase 1" clinical trials were conducted, 27 "Phase 2" clinical trials and 51 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".